Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells

导出原文传递

翻译打印收藏纠错

作者： Caldon,C.E. ^[1] ; Sergio,C.M. ^[2] ; Kang,J. ^[3] ; Muthukaruppan,A. ^[4] ; Boersma,M.N. ^[5] ; Stone,A. ; Barraclough,J. ; Lee,C.S. ; Black,M.A. ; Miller,L.D. ; Gee,J.M. ; Nicholson,R.I. ; Sutherland,R.L. ; Print,C.G. ; Musgrove,E.A.

作者单位： Department of Biochemistry, University of Otago, Dunedin, New Zealand ^[1] Welsh School of Pharmacy, Cardiff University, Cardiff, United Kingdom ^[2] Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, United States ^[3] Department of Molecular Medicine, School of Medical Sciences and the NZ Bioinformatics Institute ^[4] Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, 384 ^[5]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Molecular cancer therapeutics

2012年11卷7期

1488-1499页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells

Molecular cancer therapeutics

相似文献

Molecular cancer therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells

Molecular cancer therapeutics

相似文献

Molecular cancer therapeutics

相关期刊

检索历史清除